HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Martin Rudwaleit Selected Research
Martin Rudwaleit Research Topics
Disease
48
Ankylosing Spondylitis
12/2023 - 03/2003
34
Axial Spondyloarthritis
04/2024 - 01/2008
17
Inflammation (Inflammations)
05/2024 - 06/2006
15
Non-Radiographic Axial Spondyloarthritis
05/2024 - 01/2008
15
Sacroiliitis
05/2024 - 11/2007
12
Back Pain (Backache)
01/2019 - 02/2006
8
Arthritis (Polyarthritis)
01/2017 - 07/2003
5
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 01/2010
4
Psoriatic Arthritis
07/2011 - 07/2003
3
Spondylarthritis (Spinal Arthritis)
12/2023 - 07/2008
3
Necrosis
01/2023 - 07/2003
3
Anterior Uveitis
01/2021 - 01/2019
3
Rheumatoid Arthritis
07/2011 - 07/2003
3
Pain (Aches)
01/2011 - 03/2004
3
Infections
11/2007 - 09/2006
2
Uveitis
01/2023 - 03/2009
2
Tuberculosis (Tuberculoses)
01/2023 - 11/2007
2
Spondylarthropathies
01/2019 - 03/2004
2
Ankylosis
02/2016 - 07/2003
2
Osteitis
02/2015 - 01/2008
2
Edema (Dropsy)
12/2013 - 01/2006
2
Spinal Diseases (Disease, Spinal)
08/2010 - 07/2003
2
Crohn Disease (Crohn's Disease)
03/2008 - 06/2006
2
Low Back Pain (Lumbago)
11/2007 - 02/2006
1
Headache (Headaches)
01/2023
1
Oral Candidiasis (Thrush)
01/2023
1
Brain Diseases (Brain Disorder)
01/2023
1
Mycoses (Diseases, Fungus)
01/2023
1
Nasopharyngitis
01/2023
1
Pharyngitis (Sore Throat)
01/2023
1
Respiratory Tract Infections (Respiratory Tract Infection)
01/2023
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023
1
Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2023
1
Disease Progression
09/2015
1
Hypersensitivity (Allergy)
08/2008
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2008
1
Rheumatic Fever (Acute Articular Rheumatism)
09/2006
1
Endocarditis
09/2006
1
Dyspnea (Shortness of Breath)
06/2006
1
Coronary Vasospasm (Coronary Artery Vasospasm)
06/2006
Drug/Important Bio-Agent (IBA)
17
C-Reactive Protein
IBA
05/2024 - 05/2007
17
Adalimumab (Humira)
FDA Link
11/2023 - 07/2003
14
HLA-B27 Antigen (HLA B27 Antigen)
IBA
12/2023 - 06/2006
12
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2019 - 03/2003
11
Certolizumab Pegol
FDA Link
05/2024 - 12/2013
11
Etanercept (Enbrel)
FDA Link
11/2023 - 07/2003
11
Tumor Necrosis Factor Inhibitors
IBA
09/2022 - 07/2003
10
Infliximab (Remicade)
FDA Link
11/2016 - 03/2003
7
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
01/2023 - 04/2007
6
O,O-diisopropyl-S-benzylthiophosphate (IBP)
IBA
01/2019 - 02/2006
5
Antigens
IBA
12/2023 - 03/2003
4
Antirheumatic Agents (DMARD)
IBA
11/2023 - 07/2003
4
Cytokines
IBA
11/2011 - 03/2003
3
bimekizumab
IBA
04/2024 - 01/2023
3
HLA Antigens (Human Leukocyte Antigens)
IBA
10/2021 - 05/2007
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2020 - 01/2008
3
Biomarkers (Surrogate Marker)
IBA
01/2019 - 01/2008
3
Sulfasalazine (Azulfidine)
FDA Link
Generic
10/2014 - 07/2003
2
Monoclonal Antibodies
IBA
01/2023 - 04/2007
2
Interleukin-17 (Interleukin 17)
IBA
01/2023 - 01/2023
2
Autoantibodies
IBA
01/2023 - 01/2019
2
Fibrin
IBA
01/2021 - 12/2020
2
Fibrinogen (Factor I)
FDA Link
01/2021 - 12/2020
2
Factor XIII (Coagulation Factor XIII)
IBA
01/2021 - 12/2020
2
Immunoglobulin A (IgA)
IBA
11/2020 - 01/2019
2
Antibodies
IBA
11/2020 - 03/2007
2
Acute-Phase Proteins (Acute-Phase Protein)
IBA
05/2012 - 03/2004
1
Peptides (Polypeptides)
IBA
12/2023
1
tofacitinib
IBA
11/2023
1
secukinumab
IBA
11/2023
1
ixekizumab
IBA
11/2023
1
omega-Chloroacetophenone (Mace)
IBA
01/2023
1
Interleukins
IBA
01/2023
1
Janus Kinase Inhibitors
IBA
01/2023
1
Immunoglobulin G (IgG)
IBA
01/2019
1
Glucocorticoids
IBA
06/2017
1
Analgesics (Analgesic Drugs)
IBA
06/2017
1
Adipokines
IBA
01/2017
1
Leptin
IBA
01/2017
1
Adiponectin
IBA
01/2017
1
Naproxen (Naprosyn)
FDA Link
Generic
11/2016
1
Diclofenac (SR 38)
FDA Link
Generic
08/2016
1
N 30
IBA
10/2014
1
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
09/2014
1
golimumab
FDA Link
12/2013
1
aldosterone secretion inhibitory factor (ASIF)
IBA
09/2013
1
Rituximab (Mabthera)
FDA Link
02/2013
1
NF-kappa B (NF-kB)
IBA
08/2008
1
Interferon-gamma (Interferon, gamma)
IBA
08/2008
1
Interleukin-2 (IL2)
IBA
08/2008
1
Interferon Type I
IBA
04/2008
1
Sialic Acid Binding Ig-like Lectin 1
IBA
04/2008
1
Ergonovine (Ergometrine)
IBA
06/2006
1
Iloprost (Ventavis)
FDA Link
06/2006
Therapy/Procedure
14
Therapeutics
11/2016 - 07/2003
2
Aftercare (After-Treatment)
06/2022 - 04/2007
1
Duration of Therapy
06/2022
1
Spinal Fusion (Spondylosyndesis)
05/2009
1
Retreatment
03/2007
1
Prostheses and Implants (Prosthesis)
09/2006